Literature DB >> 34133525

PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?

Renato Gomes Campanati1, João Bernardo Sancio1, Lucas Mauro de Andrade Sucena1, Marcelo Dias Sanches1, Vivian Resende1.   

Abstract

BACKGROUND: About 50% of the patients with colorectal adenocarcinoma will present with liver metastasis and 20% are synchronic. Liver resection is associated with improvement in survival in comparison to chemotherapy alone. AIM: To analyze the overall survival in patients submitted to liver resection of colorectal cancer metastasis and prognostic factors related to the primary and secondary tumors.
METHODS: A retrospective analysis of a prospectively maintained database regarding demographic, primary tumor and liver metastasis characteristics.
RESULTS: There were 84 liver resections due to colorectal cancer metastasis in the period. The 5-year disease-free and overall survivals were 27.5% and 48.8% respectively. The statistically significant factors for survival were tumor grade (p=0.050), lymphovascular invasion (p=0.021), synchronous metastasis (p=0.020), as well as number (p=0.004), bilobar distribution (p=0.019) and diameter of the liver metastasis over 50 mm (p=0.027). Remained as independent negative predictive factors: lymphovascular invasion (HR=2.7; CI 95% 1.106-6.768; p=0.029), synchronous metastasis (HR=2.8; CI 95% 1.069-7.365; p=0.036) and four or more liver metastasis (HR=1.7; CI 95% 1.046-2.967; p=0.033).
CONCLUSION: The resection of liver metastasis of colorectal adenocarcinoma leads to good survival rates. Lymphovascular invasion was the single prognostic factor related to the primary tumor. Synchronous disease and four or more metastasis were the most significant factors related to the secondary tumor.

Entities:  

Mesh:

Year:  2021        PMID: 34133525      PMCID: PMC8195463          DOI: 10.1590/0102-672020210001e1578

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  31 in total

1.  Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis.

Authors:  Georgios A Margonis; Theodoros N Sergentanis; Ioannis Ntanasis-Stathopoulos; Nikolaos Andreatos; Ioannis-Georgios Tzanninis; Kazunari Sasaki; Theodora Psaltopoulou; Jaeyun Wang; Stefan Buettner; Αpostolos E Papalois; Jin He; Christopher L Wolfgang; Timothy M Pawlik; Matthew J Weiss
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

2.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

3.  Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.

Authors:  Kenneth Cardona; Pedro Mastrodomenico; Francesco D'Amico; Jinru Shia; Mithat Gönen; Martin R Weiser; Philip B Paty; T Peter Kingham; Peter J Allen; Ronald P De Matteo; Yuman Fong; William R Jarnagin; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

4.  Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases.

Authors:  Christoph Reissfelder; Nuh N Rahbari; Moritz Koch; Alexis Ulrich; Isabel Pfeilschifter; Anke Waltert; Sascha A Müller; Peter Schemmer; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

5.  Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases.

Authors:  Cynthia L Miller; Martin S Taylor; Motaz Qadan; Vikram Deshpande; Steven Worthington; Robert Smalley; Chey Collura; David P Ryan; Jill N Allen; Lawrence S Blaszkowsky; Jeffrey W Clark; Janet E Murphy; Aparna R Parikh; David Berger; Kenneth K Tanabe; Keith D Lillemoe; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2017-09-07       Impact factor: 3.452

6.  Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.

Authors:  B Nordlinger; M Guiguet; J C Vaillant; P Balladur; K Boudjema; P Bachellier; D Jaeck
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860

7.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

8.  IS THERE A DIFFERENCE BETWEEN RIGHT- VERSUS LEFT-SIDED COLON CANCERS? DOES SIDE MAKE ANY DIFFERENCE IN LONG-TERM FOLLOW-UP?

Authors:  Leonardo Alfonso Bustamante-Lopez; Sergio Carlos Nahas; Caio Sergio R Nahas; Rodrigo Ambar Pinto; Carlos Frederico S Marques; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2019-12-20

Review 9.  Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.

Authors:  P C Simmonds; J N Primrose; J L Colquitt; O J Garden; G J Poston; M Rees
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

10.  I BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 2: APPROACH TO RESECTABLE METASTASES.

Authors:  Héber Salvador de Castro Ribeiro; Orlando Jorge Martins Torres; Márcio Carmona Marques; Paulo Herman; Antonio Nocchi Kalil; Eduardo de Souza Martins Fernandes; Fábio Ferreira de Oliveira; Leonaldson Dos Santos Castro; Rodrigo Hanriot; Suilane Coelho Ribeiro Oliveira; Marcio Fernando Boff; Wilson Luiz da Costa; Roberto de Almeida Gil; Tulio Eduardo Flesch Pfiffer; Fabio Ferrari Makdissi; Manoel de Souza Rocha; Paulo Cezar Galvão do Amaral; Leonardo Atem Gonçalves de Araújo Costa; Tomas A Aloia
Journal:  Arq Bras Cir Dig       Date:  2016-03
View more
  2 in total

1.  Long non-coding RNA PCED1B-AS1 promotes the proliferation of colorectal adenocarcinoma through regulating the miR-633/HOXA9 axis.

Authors:  Jianfeng Liu; Jun Qian; Qi Mo; Liming Tang; Qiang Xu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

2.  RE-HEPATECTOMY MEANS MORE MORBIDITY? A MULTICENTRIC ANALYSIS.

Authors:  Luiza Basilio; Klaus Steinbrück; Reinaldo Fernandes; Marcelo D'Oliveira; Renato Cano; Hanna Vasconcelos; Daniel Barbosa; Marcelo Enne
Journal:  Arq Bras Cir Dig       Date:  2022-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.